Eloxx Pharma Q3 EPS $(0.49) Beats $(0.58) Estimate
Benzinga Newsdesk 1 day ago
NewsEarningsEarnings Beats
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
Eloxx Pharma (NASDAQ:ELOX) reported quarterly losses of $(0.49) per share which beat the analyst consensus estimate of $(0.58) by 15.52 percent. This is a 15.52 percent increase over losses of $(0.58) per share from the
Eloxx Pharma (NASDAQ:ELOX) reported quarterly losses of $(0.49) per share which beat the analyst consensus estimate of $(0.58) by 15.52 percent. This is a 15.52 percent increase over losses of $(0.58) per share from the same period last year.
